Cargando…

Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study

BACKGROUND: Though the associations between low serum 25-hydroxyvitamin D (25(OH)D) levels and health outcomes such as type 2 diabetes (T2D), myocardial infarction (MI), cancer, and mortality are well-studied, the effect of supplementation with vitamin D is uncertain. This may be related to genetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zostautiene, Ieva, Jorde, Rolf, Schirmer, Henrik, Mathiesen, Ellisiv Bøgeberg, Njølstad, Inger, Løchen, Maja-Lisa, Wilsgaard, Tom, Joakimsen, Ragnar Martin, Kamycheva, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689352/
https://www.ncbi.nlm.nih.gov/pubmed/26699871
http://dx.doi.org/10.1371/journal.pone.0145359
_version_ 1782406828191121408
author Zostautiene, Ieva
Jorde, Rolf
Schirmer, Henrik
Mathiesen, Ellisiv Bøgeberg
Njølstad, Inger
Løchen, Maja-Lisa
Wilsgaard, Tom
Joakimsen, Ragnar Martin
Kamycheva, Elena
author_facet Zostautiene, Ieva
Jorde, Rolf
Schirmer, Henrik
Mathiesen, Ellisiv Bøgeberg
Njølstad, Inger
Løchen, Maja-Lisa
Wilsgaard, Tom
Joakimsen, Ragnar Martin
Kamycheva, Elena
author_sort Zostautiene, Ieva
collection PubMed
description BACKGROUND: Though the associations between low serum 25-hydroxyvitamin D (25(OH)D) levels and health outcomes such as type 2 diabetes (T2D), myocardial infarction (MI), cancer, and mortality are well-studied, the effect of supplementation with vitamin D is uncertain. This may be related to genetic differences. Thus, rs7968585, a single nucleotide polymorphism (SNP) of the vitamin D receptor (VDR), has recently been reported as a predictor of composite health outcome. We therefore aimed to evaluate whether rs7968585 predicts separate clinical outcomes such as T2D, MI, cancer, and mortality in a community-based Norwegian population. METHODS AND FINDINGS: Measurements and DNA were obtained from the participants in the Tromsø Study in 1994–1995, registered with the outcomes of interest and a randomly selected control group. The impact of the rs7968585 genotypes was evaluated with Cox proportional hazards. A total of 8,461 subjects were included among whom 1,054 subjects were registered with T2D, 2,287 with MI, 3,166 with cancer, and 4,336 with death. Mean follow-up time from birth was 60.8 years for T2D and MI, 61.2 years for cancer, while mean follow-up time from examination date was 16.5 years for survival. Mean serum 25(OH)D levels did not differ across the rs7968585 genotypes. With the major homozygote genotype as reference, the minor homozygote subjects had hazard ratios of 1.25 (95% CI 1.05–1.49) for T2D and 1.14 (1.02–1.28) for MI (P = 0.011 and 0.023, respectively, without the Bonferroni correction). No significant interaction between serum 25(OH)D status and the rs7968585 genotype was found for any of the endpoints. CONCLUSIONS: The VDR-related SNP rs7968585 minor allele is a significant and positive predictor for T2D and possibly for MI. Since the functional mechanism of this SNP is not yet understood, and the association with T2D is reported for the first time, confirmatory studies are needed.
format Online
Article
Text
id pubmed-4689352
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46893522015-12-31 Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study Zostautiene, Ieva Jorde, Rolf Schirmer, Henrik Mathiesen, Ellisiv Bøgeberg Njølstad, Inger Løchen, Maja-Lisa Wilsgaard, Tom Joakimsen, Ragnar Martin Kamycheva, Elena PLoS One Research Article BACKGROUND: Though the associations between low serum 25-hydroxyvitamin D (25(OH)D) levels and health outcomes such as type 2 diabetes (T2D), myocardial infarction (MI), cancer, and mortality are well-studied, the effect of supplementation with vitamin D is uncertain. This may be related to genetic differences. Thus, rs7968585, a single nucleotide polymorphism (SNP) of the vitamin D receptor (VDR), has recently been reported as a predictor of composite health outcome. We therefore aimed to evaluate whether rs7968585 predicts separate clinical outcomes such as T2D, MI, cancer, and mortality in a community-based Norwegian population. METHODS AND FINDINGS: Measurements and DNA were obtained from the participants in the Tromsø Study in 1994–1995, registered with the outcomes of interest and a randomly selected control group. The impact of the rs7968585 genotypes was evaluated with Cox proportional hazards. A total of 8,461 subjects were included among whom 1,054 subjects were registered with T2D, 2,287 with MI, 3,166 with cancer, and 4,336 with death. Mean follow-up time from birth was 60.8 years for T2D and MI, 61.2 years for cancer, while mean follow-up time from examination date was 16.5 years for survival. Mean serum 25(OH)D levels did not differ across the rs7968585 genotypes. With the major homozygote genotype as reference, the minor homozygote subjects had hazard ratios of 1.25 (95% CI 1.05–1.49) for T2D and 1.14 (1.02–1.28) for MI (P = 0.011 and 0.023, respectively, without the Bonferroni correction). No significant interaction between serum 25(OH)D status and the rs7968585 genotype was found for any of the endpoints. CONCLUSIONS: The VDR-related SNP rs7968585 minor allele is a significant and positive predictor for T2D and possibly for MI. Since the functional mechanism of this SNP is not yet understood, and the association with T2D is reported for the first time, confirmatory studies are needed. Public Library of Science 2015-12-23 /pmc/articles/PMC4689352/ /pubmed/26699871 http://dx.doi.org/10.1371/journal.pone.0145359 Text en © 2015 Zostautiene et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Zostautiene, Ieva
Jorde, Rolf
Schirmer, Henrik
Mathiesen, Ellisiv Bøgeberg
Njølstad, Inger
Løchen, Maja-Lisa
Wilsgaard, Tom
Joakimsen, Ragnar Martin
Kamycheva, Elena
Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study
title Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study
title_full Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study
title_fullStr Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study
title_full_unstemmed Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study
title_short Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study
title_sort genetic variations in the vitamin d receptor predict type 2 diabetes and myocardial infarction in a community-based population: the tromsø study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689352/
https://www.ncbi.nlm.nih.gov/pubmed/26699871
http://dx.doi.org/10.1371/journal.pone.0145359
work_keys_str_mv AT zostautieneieva geneticvariationsinthevitamindreceptorpredicttype2diabetesandmyocardialinfarctioninacommunitybasedpopulationthetromsøstudy
AT jorderolf geneticvariationsinthevitamindreceptorpredicttype2diabetesandmyocardialinfarctioninacommunitybasedpopulationthetromsøstudy
AT schirmerhenrik geneticvariationsinthevitamindreceptorpredicttype2diabetesandmyocardialinfarctioninacommunitybasedpopulationthetromsøstudy
AT mathiesenellisivbøgeberg geneticvariationsinthevitamindreceptorpredicttype2diabetesandmyocardialinfarctioninacommunitybasedpopulationthetromsøstudy
AT njølstadinger geneticvariationsinthevitamindreceptorpredicttype2diabetesandmyocardialinfarctioninacommunitybasedpopulationthetromsøstudy
AT løchenmajalisa geneticvariationsinthevitamindreceptorpredicttype2diabetesandmyocardialinfarctioninacommunitybasedpopulationthetromsøstudy
AT wilsgaardtom geneticvariationsinthevitamindreceptorpredicttype2diabetesandmyocardialinfarctioninacommunitybasedpopulationthetromsøstudy
AT joakimsenragnarmartin geneticvariationsinthevitamindreceptorpredicttype2diabetesandmyocardialinfarctioninacommunitybasedpopulationthetromsøstudy
AT kamychevaelena geneticvariationsinthevitamindreceptorpredicttype2diabetesandmyocardialinfarctioninacommunitybasedpopulationthetromsøstudy